CEPHALOTHIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cephalothin, and what generic alternatives are available?
Cephalothin is a drug marketed by Intl Medication, Abbott, Abraxis Pharm, Bristol, and Baxter Hlthcare. and is included in seven NDAs.
The generic ingredient in CEPHALOTHIN is cephalothin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephalothin sodium profile page.
Summary for CEPHALOTHIN
US Patents: | 0 |
Applicants: | 5 |
NDAs: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 79 |
Clinical Trials: | 2 |
Patent Applications: | 3,863 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CEPHALOTHIN at DailyMed |
Recent Clinical Trials for CEPHALOTHIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Instituto Mexicano del Seguro Social | Phase 3 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Federal University of São Paulo | Phase 4 |
US Patents and Regulatory Information for CEPHALOTHIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intl Medication | CEPHALOTHIN | cephalothin sodium | INJECTABLE;INJECTION | 062426-002 | May 3, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Baxter Hlthcare | CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER | cephalothin sodium | INJECTABLE;INJECTION | 062422-006 | Jul 16, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbott | CEPHALOTHIN SODIUM | cephalothin sodium | INJECTABLE;INJECTION | 062547-002 | Sep 11, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Intl Medication | CEPHALOTHIN | cephalothin sodium | INJECTABLE;INJECTION | 062426-001 | May 3, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |